Your browser doesn't support javascript.
loading
Multi-modal Proteomic Characterization of Lysosomal Function and Proteostasis in Progranulin-Deficient Neurons.
Hasan, Saadia; Fernandopulle, Michael S; Humble, Stewart W; Frankenfield, Ashley M; Li, Haorong; Prestil, Ryan; Johnson, Kory R; Ryan, Brent J; Wade-Martins, Richard; Ward, Michael E; Hao, Ling.
Affiliation
  • Hasan S; National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Fernandopulle MS; UK Dementia Research Institute, Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK.
  • Humble SW; MD-PhD program, Augusta University/University of Georgia Medical Partnership, Athens, GA, USA.
  • Frankenfield AM; National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Li H; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
  • Prestil R; Medical Scientist Training Program, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Johnson KR; National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Ryan BJ; Oxford Parkinson's Disease Centre, Kavli Institute for Nanoscience Discovery, Department of Physiology, Anatomy and Genetics, Dorothy Crowfoot Hodgkin Building, University of Oxford, South Parks Road, Oxford, OX1 3QU UK.
  • Wade-Martins R; Department of Chemistry, George Washington University, Washington, DC, USA.
  • Ward ME; Department of Chemistry, George Washington University, Washington, DC, USA.
  • Hao L; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
bioRxiv ; 2023 Feb 24.
Article in En | MEDLINE | ID: mdl-36865171
Progranulin (PGRN) is a lysosomal protein implicated in various neurodegenerative diseases. Over 70 mutations discovered in the GRN gene all result in reduced expression of PGRN protein. However, the detailed molecular function of PGRN within lysosomes and the impact of PGRN deficiency on lysosomal biology remain unclear. Here we leveraged multifaceted proteomic techniques to comprehensively characterize how PGRN deficiency changes the molecular and functional landscape of neuronal lysosomes. Using lysosome proximity labeling and immuno-purification of intact lysosomes, we characterized lysosome compositions and interactomes in both human induced pluripotent stem cell (iPSC)-derived glutamatergic neurons (i3Neurons) and mouse brains. Using dynamic stable isotope labeling by amino acids in cell culture (dSILAC) proteomics, we measured global protein half-lives in i3Neurons for the first time and characterized the impact of progranulin deficiency on neuronal proteostasis. Together, this study indicated that PGRN loss impairs the lysosome's degradative capacity with increased levels of v-ATPase subunits on the lysosome membrane, increased catabolic enzymes within the lysosome, elevated lysosomal pH, and pronounced alterations in neuron protein turnover. Collectively, these results suggested PGRN as a critical regulator of lysosomal pH and degradative capacity, which in turn influences global proteostasis in neurons. The multi-modal techniques developed here also provided useful data resources and tools to study the highly dynamic lysosome biology in neurons.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States